help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 17, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0847
A more recent version of this article appeared on September 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/9/3510    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Luigi, L.
Right arrow Articles by Guidetti, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Luigi, L.
Right arrow Articles by Guidetti, L.
Related Collections
Right arrow Male Endocrinology

Submitted on April 18, 2008
Accepted on June 6, 2008

The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men

Luigi Di Luigi*, Carlo Baldari, Paolo Sgrò, Gian Pietro Emerenziani, Maria Chiara Gallotta, Serena Bianchini, Francesco Romanelli, Fabio Pigozzi, Andrea Lenzi, and Laura Guidetti

Unit of Endocrinology (L.D.L., P.S., S.B.), and Unit of Sport Sciences (C.B., G.P.E.), and Unit of Exercise Sciences (M.C.G., L.G.), and Unit of Sport Medicine (F.P.), Department of Health Sciences, University of Rome "IUSM", 00194 Rome, Italy; Department of Medical Physiopathology (F.R., A.L.), University of Rome "La Sapienza", 00161 Rome, Italy

* To whom correspondence should be addressed. E-mail: luigi.diluigi{at}iusm.it.

Context: Physical exercise-related stress activate hypothalamus-pituitary-adrenal (HPA) axis, nitric oxide (NO) is one of the mediators of the HPA axis response to stress, and phosphodiesterase's type 5 inhibitors (PDE5i) influences NO-linked biological activities.

Objective: To investigate whether a single oral long half-life PDE5i (tadalafil) administration influences the HPA axis response to exercise-related stress.

Design: Double blind crossover trial

Participants: Nine healthy male athletes

Interventions: All subjects performed a maximal exercise test in normoxia, after received a single oral administration of tadalafil or placebo. Then, after a 2-weeks washout period, they were crossed over and repeated the exercise test. Each subject was is own control. Salivary collections, for steroids evaluations [cortisol, dehydroepiandrosterone sulphate (DHEAS), testosterone] and respective ratios calculation (DHEAS/cortisol, testosterone/cortisol, testosterone/DHEAS), were performed before each exercise (Pre-Ex), immediately after (Post-Ex), and at thirty minutes during recovery.

Results: As expected mean salivary cortisol concentration increased immediately after exercise both after tadalafil and placebo (p = 0.014, and p =0.036 vs Pre-Ex, respectively), however, the cortisol increase was significantly higher after tadalafil administration (p = 0.034 vs placebo). Furthermore, an increased salivary testosterone after exercise was observed only after tadalafil administration (p = 0.029 vs Pre-Ex). No effects of either exercise and/or tadalafil administration on salivary DHEAS concentrations were observed. DHEAS/cortisol and testosterone/cortisol ratios significantly decreased after exercise after tadalafil administration (p = 0.037, and p = 0.02 vs placebo, respectively).

Conclusion: Tadalafil administration amplified the salivary cortisol and testosterone responses to a maximal exercise-related stress in healthy trained humans.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society